Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on March 7, 2013. The report discloses a material corporate event regarding the pricing of a new debt offering.
Key Financial Metrics
The filing details a capital raise rather than operational performance metrics. Key figures include:
- Debt Issuance: $150 million aggregate principal amount.
- Instrument Type: Senior unsecured notes.
- Maturity Date: 2021.
- Placement Method: Private placement to qualified institutional buyers (Rule 144A) and non-U.S. persons (Regulation S).
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing liquidity positions.
Material Changes
The primary material change is the expansion of the company's debt capital structure through the issuance of the $150 million senior unsecured notes. No comparative period financial data is included in this specific filing.
Outlook, Risks, and Management Commentary
Management announced the pricing of the notes via a press release attached as Exhibit 99. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard disclosure of the debt offering mechanics.
Investor Verification Checklist
- Verify the interest rate and yield of the $150 million senior unsecured notes due 2021 in the attached press release (Exhibit 99).
- Confirm the intended use of proceeds from the offering.
- Review the company's updated total debt load and leverage ratios post-issuance.
- Check for any covenants associated with the new senior unsecured notes.